| Particulars |
|
|
|
| Company Name
| Lincoln Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
20.03 |
B.V. (₹) |
357.40 |
| Sales(₹ Cr.) |
623.23 |
NP (₹ Cr.) |
81.03 |
| NP Var (%) |
-12.00 |
Div% |
18.00 |
| CPS(₹) |
46.90 |
EPS (₹) |
40.50 |
| Traded Value(₹ Lakhs) |
19.97 |
52 Week High |
750.00 |
| 52 Week Low |
440.00 |
Price BSE |
717.00 |
| P/C Ratio |
15.30 |
P/E Ratio |
17.70 |
| Price Vs.BV |
2.01 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
166.32 |
| NP(₹ Cr.) |
28.60 |
NP Var % |
38.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
597.44 |
| OPM |
16.60 |
NP |
96.64 |
| NP Var (%) |
-1.72 |
EPS |
43.85 |
| PE |
16.36 |
|
|